The impact of second-line agents on patients’ health-related quality of life in the treatment for non-small cell lung cancer: a systematic review

被引：0
|
作者：
Arijit Ganguli
Phillip Wiegand
Xin Gao
John A. Carter
Marc F. Botteman
Saurabh Ray
机构：
[1] Abbott Laboratories,
[2] Pharmerit International,undefined
来源：
Quality of Life Research | 2013年 / 22卷
关键词：
Non-small cell lung cancer; Quality of life; Second line;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1015 / 1026
页数：11
相关论文
共 50 条
  • [1] The impact of second-line agents on patients' health-related quality of life in the treatment for non-small cell lung cancer: a systematic review
    Ganguli, Arijit
    Wiegand, Phillip
    Gao, Xin
    Carter, John A.
    Botteman, Marc F.
    Ray, Saurabh
    [J]. QUALITY OF LIFE RESEARCH, 2013, 22 (05) : 1015 - 1026
  • [2] Second-line treatment for advanced non-small cell lung cancer:: A systematic review
    Barlési, F
    Jacot, W
    Astoul, P
    Pujol, JL
    [J]. LUNG CANCER, 2006, 51 (02) : 159 - 172
  • [3] Single agents in the second-line treatment of non-small cell lung cancer
    Belani, CP
    [J]. SEMINARS IN ONCOLOGY, 1998, 25 (03) : 10 - 14
  • [4] Health-related quality of life and tolerability of pemetrexed with or without enzastaurin as second-line therapy for advanced non-small cell lung cancer
    Reck, Martin
    Chiappori, Alberto
    Liepa, Astra M.
    Zhao, Yan D.
    Mazieres, Julien
    Schwartzberg, Lee S.
    von Pawel, Joachim
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S707 - S708
  • [5] Health-related queality of life after surgical treatment in patients with non-small cell lung cancer: A systematic review
    Poghosyan, Hermine
    Sheldon, Lisa Kennedy
    Leveille, Suzanne G.
    Cooley, Mary E.
    [J]. LUNG CANCER, 2013, 81 (01) : 11 - 26
  • [6] Health-related quality of life in patients surviving non-small cell lung cancer
    Grutters, Janneke P. C.
    Joore, Manuela A.
    Wiegman, Erwin M.
    Langendijk, Johannes A.
    de Ruysscher, Dirk
    Hochstenbag, Monique
    Botterweck, Anita
    Lambin, Philippe
    Pijls-Johannesma, Madelon
    [J]. THORAX, 2010, 65 (10) : 903 - 907
  • [7] HEALTH-RELATED QUALITY OF LIFE IN PATIENTS SURVIVING NON-SMALL CELL LUNG CANCER
    Grutters, J.
    Joore, M.
    Wiegman, E.
    Langendijk, H.
    De Ruysscher, D.
    Hochstenbag, M.
    Botterweck, A.
    Lambin, P.
    Pijls-Johannesma, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S344 - S345
  • [8] Second-line treatment of advanced non-small cell lung cancer
    Gridelli, Cesare
    Ardizzoni, Andrea
    Ciardiello, Fortunato
    Hanna, Nasser
    Heymach, John V.
    Perrone, Francesco
    Rosell, Rafael
    Shepherd, Frances A.
    Thatcher, Nick
    Vansteenkiste, Johan
    De Petris, Luigi
    Di Maio, Massimo
    De Marinis, Filippo
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (04) : 430 - 440
  • [9] Histologic review of second-line permetrexed treatment in patients with non-small cell lung cancer (NSCLC)
    Virani, S.
    Almubarak, M.
    Rogers, J. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] The effects of tislelizumab treatment on the health-related quality of life of patients with advanced non-small cell lung cancer
    Huang, Dingzhi
    Zhou, Caicun
    Barnes, Gisoo
    Ma, Yiyuan
    Li, Songzi
    Zhan, Lin
    Tang, Boxiong
    [J]. CANCER MEDICINE, 2023, 12 (16): : 17403 - 17412
12345